"we held a meeting with payers (e.g., Medicare/Medicaid and insurance companies) to discuss the impact of Parkinson's symptoms, including "off" episodes. That knowledge may impact decisions on medication coverage"
Imagine if they would make this available at a price affordable to the masses - they would have to "give" up their monopoly on it-make manufacture available to generic manufacturers? For those of us who can't afford any type of insurance but don't fit into medicare or medicaid brackets either....It would be a master play of the big players -change of the guard....using the current system in a new way--levadopa is an old already discovered drug-but dosage and how it is delivered finnesses its application and VALUE.. We already have so many "cures" - not that finding new ones isn't valuable too...its just that there is something to be said for the simple things in life that we take for granted. Sometimes the way out is through. What with depression amongst our youth and 5G EMF signalling massive dopamine depletion the balancing potential in this appears .....mind boggling- sigh

Why is this an application specific to "off" episodes only?